[Letter of Priority Distributorship Authorization]


DiaPlexQ™ 2019-nCoV Detection Kit

FDA-EUA Approved

  • DiaPlexQ™ Novel Coronavirus(2019-nCov) Detection Kit is a CE-IVD assay reagent.

  • It is designed to detect the nucleic acid of novel coronavirus contained in total RNA extracted from blood suspected patients.

  • The kit is based on Real-Time RT PCR method.

  • Additional reagent purchase is not needed, as 5 components are equipped required for PCR reaction.

  • SolGent's OneStep qRT-PCR method performs RT reaction and Real-time PCR amplification reaction sequentially in one tube without separate experiment for RT reaction.

  • Detection time, cost and sensitivity were improved compared to conventional PCR diagnosis.

Direct Contact Info

*For inquiries,
please contact the following E-mail address


CAREMiLE Inc., L&K 3F,  556, Nonhyeon-ro,  Gangnam-gu, Seoul, Republic of Korea, 06136

​ 대한민국, 서울시, 강남구, 논현로 556,

엘엔케이 빌딩 3층 (우) 06136


Phone: +82 .1644. 8567

Email:  info@caremile.co.kr

© 2021 by CAREMILE Inc.